CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

53.47 -1.85 (-3.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Price and Volume

Volume	2,436,840
Open	54.55
Bid (Size)	53.10 (200)
Ask (Size)	53.90 (600)
Prev. Close	55.32
Today's Range	52.07 - 54.99
52wk Range	30.04 - 78.48
Shares Outstanding	78,935,098
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Underrated Stock That Could Soar by 58%, According to Wall Street ↗

November 17, 2025

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

Via The Motley Fool

The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market

November 14, 2025

The global financial markets are in the midst of a profound transformation, driven by an accelerating wave of technological advancements. From the intricate algorithms of Artificial Intelligence to the...

Via MarketMinute

Performance

YTD	+29.1%	+29.1%
1 Month	-27.7%	-27.7%
3 Month	-1.3%	-1.3%
6 Month	+36.2%	+36.2%
1 Year	+13.0%	+13.0%

More News

ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried? ↗

November 12, 2025

Via The Motley Fool

Retail Bulls Call CRISPR ‘Criminally Undervalued’ After Gene-Editing Breakthrough Cuts Cholesterol By 70% ↗

November 10, 2025

Via Stocktwits

CRISPR Therapeutics' Investigational Gene Therapy Shows Promising Lipid-Lowering Effects In Early Trial ↗

November 11, 2025

Via Benzinga

Why Gene-Editing Giants Crispr And Intellia Just Surged ↗

November 10, 2025

Via Investor's Business Daily

Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗

November 07, 2025

Via Investor's Business Daily

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

Via TokenRing AI

Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗

November 04, 2025

Via Benzinga

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

Via TokenRing AI

Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 2 Years From Now ↗

November 04, 2025

Via The Motley Fool

Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗

October 27, 2025

Via Benzinga

2 Soaring Cathie Wood Stocks to Buy and Hold ↗

October 17, 2025

Via The Motley Fool

New to Growth Stocks? Here's 1 Every Investor Should Have on Their Radar. ↗

October 16, 2025

Via The Motley Fool

3 Monster Stocks to Hold for the Next 10 Years ↗

October 15, 2025

Via The Motley Fool

4 Healthcare Stocks to Buy Now ↗

October 12, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

October 08, 2025

Via Benzinga

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead ↗

October 08, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

October 03, 2025

Via Benzinga

Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors

October 04, 2025

Via MarketMinute

3 Growth Stocks That Could Be 10-Baggers in 10 Years ↗

October 03, 2025

Via The Motley Fool

Got $200? 2 Healthcare Stocks to Buy and Hold Forever ↗

October 01, 2025

Via The Motley Fool

Could This Beaten-Down Stock Help You Become a Millionaire? ↗

September 30, 2025

Via The Motley Fool

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

Via MarketMinute

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Via Benzinga

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?

Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.

What exchange does CRISPR Therapeutics AG - Common Shares trade on?

CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?

The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market

What is the current price of CRISPR Therapeutics AG - Common Shares?

The current price of CRISPR Therapeutics AG - Common Shares is 53.47

When was CRISPR Therapeutics AG - Common Shares last traded?

The last trade of CRISPR Therapeutics AG - Common Shares was at 11/18/25 04:00 PM ET

What is the market capitalization of CRISPR Therapeutics AG - Common Shares?

The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.22B

How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?

CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.